title: Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument.
abstract: The COBAS TaqMan HCV Test (TaqMan HCV; Roche Molecular Systems Inc., Branchburg, N.J.) for hepatitis C virus (HCV) performed on the COBAS TaqMan 48 Analyzer (Roche Molecular Systems) currently relies on a manual sample processing method. Implementation of an automated sample processing method would facilitate the clinical use of this test. In this study, we evaluated the performance characteristics of TaqMan HCV following automated sample processing by the MagNA Pure LC instrument (MP; Roche Applied Science, Indianapolis, Ind.). The analytical sensitivity of TaqMan HCV following sample processing by MP was 8.1 IU/ml (95% confidence interval, 6.1 to 15.2). The assay showed good linearity (R(2) = 0.99) across a wide range of HCV RNA levels (25 to 5 x 10(6) IU/ml), with coefficients of variation ranging from 10% to 46%. Among 83 clinical specimens, the sensitivity and specificity of TaqMan HCV were 100% and 95%, respectively, when compared to the COBAS AMPLICOR hepatitis C virus test, version 2.0 (COBAS AMPLICOR; Roche Molecular Systems), with TaqMan HCV detecting two more HCV RNA-positive specimens than COBAS AMPLICOR. Both specimens were confirmed to be HCV RNA positive by the VERSANT HCV RNA qualitative test (Bayer HealthCare LLC, Tarrytown, N.Y.). There was also strong correlation (R(2) = 0.95) and good agreement between the results from TaqMan HCV and the VERSANT HCV RNA 3.0 assay (bDNA) (Bayer HealthCare LLC) among a group of 93 clinical specimens. The MP is a versatile, labor-saving sample processing platform suitable for reliable performance of TaqMan HCV.
authors.affiliation: Division of Clinical Microbiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Germer
authors.forename: W Scott
authors.initials: WS
authors.lastname: Harmsen
authors.forename: Jayawant N
authors.initials: JN
authors.lastname: Mandrekar
authors.forename: P Shawn
authors.initials: PS
authors.lastname: Mitchell
authors.forename: Joseph D C
authors.initials: JD
authors.lastname: Yao
mesh_terms: D001331:Automation; D016174:Hepacivirus / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D006526:Hepatitis C / Q000175:diagnosis* / Q000821:virology; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000295:instrumentation / Q000379:methods; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood* / Q000302:isolation & purification; D012680:Sensitivity and Specificity; D019914:Taq Polymerase; D019562:Viral Load
chemical_list: D012367:RNA, Viral; D019914:Taq Polymerase